Telehealth Consent

Last Updated: September 8, 2026

EMERGENCY NOTICE

Telehealth is not appropriate for medical emergencies.

If you are experiencing a medical emergency, call 911 or go to the nearest emergency department immediately.

If you are in crisis or having thoughts of harming yourself, call or text 988 to reach the 988 Suicide & Crisis Lifeline, available 24 hours a day.

Do not use the Service, and do not wait for a response from a Provider, in any of these situations. Providers do not monitor the Service continuously and may not see or respond to your message promptly.

ACCEPTANCE

By clicking "I Agree," checking a box indicating your acceptance, electronically signing this document, or otherwise affirmatively accepting this Consent through the Service, you acknowledge that:

  • you have read this Consent in full;
  • you have had the opportunity to ask questions about it;
  • you understand its contents; and
  • you voluntarily agree to receive healthcare services by telehealth on the terms described.

You must be at least 18 years of age to use the Service. The Service is not offered to, and may not be used by or on behalf of, any person under 18. If you are under 18, do not create an account or use the Service.

If you do not agree to this Consent, do not create an account and do not use the Service. You may withdraw your consent at any time as described in Section 15.

You may download, print, and retain a copy of this Consent at any time. A copy will also be available in your account.

1. DEFINITIONS

"Consent" means this Informed Consent to Telehealth Services, as amended from time to time.

"Medical Group" means Nexlife Medical Group P.C. and its affiliated professional entities, which employ or contract with the Providers who furnish clinical services to you.

"Nexlife" means Nexlife Inc., which owns and operates the technology platform and provides administrative and care-coordination services.

"Partner Pharmacy" means a licensed pharmacy that may dispense a medication prescribed to you, as described in Section 10.

"Provider" means a physician, physician assistant, or nurse practitioner who is licensed in your state and who is employed by or contracted with the Medical Group.

"Service" means the Nexlife website, patient portal, mobile applications, messaging system, and related technology through which telehealth services are made available.

"you" and "your" mean the individual, aged 18 or older, who uses the Service.

2. WHO PROVIDES YOUR CARE

2.1 The Medical Group provides clinical services

All clinical services — including medical evaluation, diagnosis, treatment planning, prescribing, and clinical follow-up — are provided exclusively by Nexlife Medical Group P.C. and its affiliated professional entities, through Providers licensed in the state where you are located at the time of service.

Your Provider exercises independent professional medical judgment. Your Provider alone determines whether any treatment is clinically appropriate for you, and may prescribe, decline to prescribe, adjust, pause, or discontinue treatment at any time based on clinical appropriateness, your medical history, contraindications, and applicable law.

2.2 Nexlife does not practice medicine

Nexlife Inc. is a technology and administrative services company. Nexlife:

  • does not practice medicine;
  • does not provide medical advice;
  • does not employ your Provider;
  • does not participate in, direct, or influence any clinical decision, including any decision to prescribe;
  • is not a pharmacy and does not manufacture, compound, test, label, or dispense any medication; and
  • is not a licensed healthcare facility.

2.3 Financial relationship — required disclosure

Nexlife Inc. has a financial relationship with Nexlife Medical Group P.C. Nexlife provides administrative, technology, marketing, and management services to the Medical Group and is compensated for those services.

This relationship does not give Nexlife any authority over clinical decisions. You should nonetheless be aware of it when evaluating information presented to you through the Service.

You are free to obtain a medical evaluation, a second opinion, or any treatment from any healthcare provider not affiliated with Nexlife or the Medical Group.

2.4 Your Provider may not be a physician

Depending on your state and the nature of your care, your treating Provider may be a physician assistant or a nurse practitioner rather than a physician. By accepting this Consent, you agree to receive care from a non-physician Provider where applicable. Physician assistants and nurse practitioners practice under supervision or collaboration arrangements as required by the law of your state.

2.5 No guarantee of a specific Provider

You may not be assigned the same Provider for every interaction. The Service may route your care to any Provider licensed in your state. You may request a different Provider by contacting support.

2.6 No provider–patient relationship until acceptance

Completing an online health assessment, creating an account, or making a payment does not create a provider–patient relationship and does not entitle you to any prescription or treatment.

A provider–patient relationship is established only when a Provider reviews your information and affirmatively accepts you for care.

3. WHAT TELEHEALTH IS

Telehealth is the delivery of healthcare services using electronic communications between a patient and a provider who are not in the same physical location.

3.1 Modalities used by the Medical Group

Your care may be delivered through either or both of the following:

(a) Synchronous telehealth — real-time interaction between you and your Provider by live video or live audio.

(b) Asynchronous telehealth (store-and-forward) — your Provider reviews information you submit — including your health assessment responses, medical history, photographs, laboratory results, and messages — at a different time than when you submit it, and without a live conversation.

You may receive a diagnosis, a treatment plan, and a prescription based on an asynchronous review alone, without ever speaking to or seeing your Provider in real time, where permitted by the law of your state and where your Provider determines it is clinically appropriate.

Some states require a synchronous encounter before certain medications may be prescribed. Where your state requires it, or where your Provider determines it is clinically necessary, a live video or audio visit will be arranged.

3.2 What telehealth may include

  • Electronic transmission of medical records, photographs, health information, and other data between you and your Provider
  • Live video or audio consultation
  • Secure messaging within the Service
  • Review of results from at-home or laboratory diagnostic testing
  • Review of data you choose to share from consumer health devices or applications
  • Electronic prescribing to a Partner Pharmacy or a pharmacy of your choice

3.3 In-person care is an alternative

You may choose to receive care in person from a provider of your choosing at any time, and you may do so instead of or in addition to using the Service. You are encouraged to discuss this option with your Provider. Providers who furnish services through the Service do not offer in-person care.

4. POSSIBLE BENEFITS OF TELEHEALTH

Telehealth may:

  • improve your access to care, including where local providers are unavailable or scheduling is difficult;
  • allow you to receive care at times and locations convenient to you;
  • reduce travel and time away from work; and
  • allow more frequent follow-up contact with a Provider than in-person care might permit.

No benefit is guaranteed. Telehealth may not produce any of these benefits in your case.

5. RISKS AND LIMITATIONS OF TELEHEALTH

Telehealth carries risks and limitations that differ from those of in-person care. You should understand each of the following before consenting.

5.1 Limitations of remote evaluation

  • No physical examination. Your Provider cannot palpate, auscultate, or otherwise physically examine you, and cannot directly measure your vital signs, weight, or other physical findings.
  • Reliance on self-reported information. Your Provider's evaluation depends substantially on information you supply. Information that is incomplete, inaccurate, or misunderstood may lead to an incorrect assessment.
  • Missed findings. Conditions that would be detected on physical examination may go undetected. This includes conditions unrelated to the reason you sought care, and conditions that would make a treatment unsafe for you.
  • Missed urgency. Your Provider may not recognize that your condition requires immediate, in-person, or emergency care.
  • Incomplete records. Your Provider may not have access to your complete medical history, prior imaging, prior laboratory results, or records from other treating providers. This increases the risk of adverse drug interactions, allergic reactions, duplicate therapy, and other errors.

5.2 Risks specific to asynchronous care

Where your care is delivered asynchronously:

  • you will not have a real-time opportunity to ask questions before a treatment decision is made;
  • your Provider cannot ask follow-up questions in the moment, and must rely on your written responses;
  • nuance, context, and symptoms you did not think to report may not be captured; and
  • the interval between your submission and your Provider's review may delay identification of a condition requiring prompt attention.

5.3 Technology risks

  • The Service may contain errors or defects, may become unavailable, or may fail to transmit information accurately or at all.
  • Records, messages, images, or data may be delayed, corrupted, incomplete, or lost.
  • Video or audio quality may be degraded, which may impair your Provider's ability to evaluate you.
  • Technology failures may affect the quality, accuracy, and effectiveness of your care.

5.4 Privacy and security risks

  • Despite reasonable safeguards, electronic storage and transmission of health information carries an inherent risk of unauthorized access, interception, or disclosure.
  • Email and text message are less secure than messaging within the Service. Information you send by those means may be exposed to third parties, including your own email or mobile carrier.
  • Persons in your physical vicinity may overhear or observe a video or audio consultation. You are responsible for choosing a private location.

5.5 Regulatory limitations

  • The law of your state may restrict what your Provider can diagnose, treat, or prescribe by telehealth, and may restrict the use of asynchronous care for certain medications.
  • Services available in one state may be unavailable in another.
  • Your Provider must be licensed in the state where you are physically located at the time of service. You must accurately report your location.

5.6 Clinical outcome risks

  • No diagnosis, treatment, or outcome is guaranteed. Your condition may not improve, and may worsen.
  • Any treatment carries a risk of side effects, adverse reactions, and complications, some of which may be serious, permanent, or life-threatening.
  • You may require additional care, including emergency or in-person care, that the Service cannot provide.

6. YOUR RESPONSIBILITIES

By accepting this Consent, you agree to:

(a) Provide complete and truthful information. You must give the Medical Group and your Provider accurate, current, and complete information about your health, including your medical history, all diagnoses, all medications and supplements you take, all allergies, all prior adverse reactions, any pregnancy or plan to become pregnant, and any care you are receiving from other providers.

Withholding or providing inaccurate information about your health or medical history in order to obtain treatment may result in serious harm, including, in some cases, death.

(b) Report your location accurately. You must be physically located in a state where the Medical Group is licensed and where fulfillment is permitted, at the time of each service, and you must report that location accurately.

(c) Update your information. You must promptly inform your Provider of any change in your health, medications, or condition, and of any side effect or adverse reaction.

(d) Follow instructions. You must follow your Provider's instructions and the written instructions supplied with any medication, and must not change your dose, schedule, or method of administration without first consulting your Provider.

(e) Maintain the confidentiality of your account. You must not share your login credentials, and you must not permit anyone else to use your account or to obtain treatment through it.

(f) Seek emergency care when needed. You must not use the Service in place of emergency or urgent care.

7. EMERGENCIES, URGENT CARE, AND CONTINUITY

7.1 Telehealth is not emergency care

The Service is not designed, staffed, or intended for emergencies. Providers do not monitor the Service continuously. Never rely on the Service in an emergency.

7.2 What to do

Situation What to do
Medical emergency Call 911 or go to the nearest emergency department
Thoughts of self-harm or suicide Call or text 988
Urgent but non-emergency care Contact your primary care provider, an urgent care center, or an emergency department
Non-urgent clinical question Message your Provider through the Service
Technical problem preventing you from messaging Call (949) 818-8000

7.3 Continuity of care

The Service is not a substitute for a primary care provider. You are encouraged to maintain a relationship with a primary care provider and to inform that provider of any treatment you receive through the Service.

You should tell every healthcare professional who treats you — including any surgeon, anesthesiologist, dentist, or proceduralist — about every medication you are taking through the Service.

8. COMPOUNDED MEDICATIONS

This section requires FDA regulatory counsel approval before publication.

8.1 Your Provider may prescribe a compounded medication

Your Provider may determine that a compounded medication is clinically appropriate for you. A compounded medication is prepared by a licensed pharmacy for an individual patient pursuant to a prescription.

8.2 Compounded medications are not FDA-approved

Compounded medications are not approved by the U.S. Food and Drug Administration. They have not been evaluated by the FDA for safety, effectiveness, or quality, and they do not undergo the clinical studies required of FDA-approved commercially available medications.

FDA-approved alternatives to compounded semaglutide and compounded tirzepatide exist. You are encouraged to discuss both FDA-approved and compounded options with your Provider, including the differences between them, before you begin treatment.

Compounded semaglutide is not Ozempic® or Wegovy®. Compounded tirzepatide is not Mounjaro® or Zepbound®. Nexlife and the Medical Group are not affiliated with, endorsed by, or sponsored by Novo Nordisk A/S or Eli Lilly and Company.

8.3 Compounded medications may differ from commercial products

A compounded medication may differ from a commercially available product in concentration, inactive ingredients, appearance, packaging, and labeling. Some formulations may contain additional ingredients, which may include methylcobalamin (Vitamin B12), glycine, or pyridoxine (Vitamin B6). Composition may vary by pharmacy and by prescription.

Ask your Partner Pharmacy what your specific formulation contains, and tell your Provider about any allergy or sensitivity to any component.

8.4 Multi-dose vials and dosing

Compounded GLP-1 medications are commonly dispensed in multi-dose vials, which require you to measure and draw each dose yourself.

Your dose is prescribed in milligrams (mg) or milliliters (mL) — not in insulin units. Syringes marked in insulin units are not interchangeable with a dose expressed in milligrams. Measuring a dose in insulin units can result in an overdose of ten times the intended amount.

Before your first injection you must:

  1. read the written instructions supplied with your medication in full;
  2. confirm with your Provider or the dispensing pharmacy exactly what volume to draw and what syringe to use; and
  3. if the written instructions, the vial label, and what you were told do not agree, not inject — and instead contact your Provider or the dispensing pharmacy.

Never share needles or syringes with any other person. Sharing poses a risk of serious infection.

If you believe you have injected more than your prescribed dose, contact your Provider or seek medical attention immediately.

8.5 You must read the Important Safety Information

Before beginning treatment, you must read the Important Safety Information in full, including the boxed warning regarding thyroid C-cell tumors, the contraindications, the serious risks, the drug interactions, and the instructions regarding surgery and anesthesia.

By accepting this Consent, you acknowledge that you have been directed to that information and have had the opportunity to read it and to discuss it with your Provider.

9. PRIVACY, SECURITY, AND RECORDING

9.1 Protected health information

Information that identifies you and relates to your health is protected health information. It will not be disclosed to any third party without your authorization except as permitted or required by law, including for treatment, payment, healthcare operations, and mandatory reporting obligations, and as described in the Medical Group's Notice of Privacy Practices.

9.2 Safeguards

The Service uses administrative, technical, and physical safeguards intended to protect the confidentiality, integrity, and availability of your information. No system can be guaranteed secure.

9.3 Your choice of communication method

If you choose to communicate by email or text message, you accept the additional privacy risk described in Section 5.4. You may instead use the secure messaging function within the Service.

9.4 Recording

Clinical consultations are not recorded unless you are notified in advance and, where required by law, provide separate consent.

Administrative and support calls may be recorded or monitored for quality assurance, training, and compliance purposes, where permitted by law. In states requiring all-party consent, you will be notified at the start of the call.

9.5 Health data from devices and applications

If you choose to connect a consumer health device or application, you authorize the Medical Group to receive and review that data. Data from consumer devices is not a substitute for medical evaluation and may be inaccurate. You may disconnect at any time.

9.6 Access to your records

You have the right to access and to request a copy of your medical records, and to request an amendment, as described in the Notice of Privacy Practices. Contact support to make a request.

10. PRESCRIPTIONS AND PHARMACY

10.1 No entitlement to a prescription

A prescription is not guaranteed. Enrollment, payment, or completion of an assessment does not entitle you to a prescription. Your Provider may decline to prescribe.

If your Provider declines to prescribe, refunds are governed by the Refund Policy.

10.2 Partner Pharmacies

If a medication is prescribed, it may be dispensed by a licensed U.S. pharmacy within Nexlife's partner network and shipped to you as permitted by law. The pharmacy used may vary based on your location, your Provider's direction, formulation availability, and applicable law.

A current list of partner pharmacies is available at nnexliferx.com or on request by contacting support at (949) 818-8000.

10.3 Your right to choose your pharmacy

You have the right to have your prescription filled at any pharmacy you choose. Contact support at (949) 818-8000 to have your prescription sent to a pharmacy of your choosing. Choosing a non-partner pharmacy may affect the price you pay and what your program includes.

Prescriptions may be transferred between Partner Pharmacies on your behalf where necessary for fulfillment.

10.4 Shipping and storage

Medications are shipped to the address you provide. You are responsible for receiving and storing your medication as directed, including any refrigeration requirement. Contact the dispensing pharmacy if your shipment is delayed, damaged, or arrives at an incorrect temperature.

11. LABORATORY AND DIAGNOSTIC TESTING

Some services may require laboratory or at-home diagnostic testing performed by third-party laboratories.

Neither Nexlife nor the Medical Group can guarantee the accuracy or reliability of any test. Tests may produce false negative, false positive, or inconclusive results, and defects in collection, handling, or processing may affect results. An inaccurate result may lead to an incorrect assessment or treatment decision.

If a test requires self-collection, you must follow the collection instructions exactly. Improper collection is a common cause of inaccurate results.

12. PAYMENT AND INSURANCE

12.1 Self-pay

The Service operates on a self-pay basis. You are responsible for the full cost of all services and medications.

12.2 No insurance billing

Neither Nexlife nor the Medical Group bills insurance. You agree not to submit, and not to cause any person to submit, a claim for any amount paid for the Service to Medicare, Medicaid, TRICARE, any other federal or state healthcare program, or any private insurer.

12.3 FSA and HSA

Some members use funds from a flexible spending account (FSA) or health savings account (HSA). Whether your expenses are eligible depends on your plan and on a determination of medical necessity. Check with your plan administrator. Use of FSA or HSA funds is not the submission of an insurance claim.

12.4 Billing terms

Pricing, billing frequency, cancellation, and refunds are governed by the Terms & Conditions and the Refund Policy.

13. TREATMENT ALTERNATIVES

You have the right to be informed of alternatives to any treatment your Provider recommends. Alternatives may include:

  • FDA-approved medications, including brand-name products;
  • non-pharmacologic approaches, including nutrition, physical activity, and behavioral change;
  • referral to a specialist, including an endocrinologist or an obesity medicine physician;
  • surgical options, where clinically appropriate; and
  • no treatment.

Discuss the risks and benefits of each alternative with your Provider before beginning treatment. You may decline any recommended treatment.

14. TERMINATION BY THE MEDICAL GROUP

A Provider or the Medical Group may decline to begin, or may discontinue, treatment at any time — including where a Provider determines treatment is not clinically appropriate, where you do not provide accurate information, where you do not comply with monitoring or follow-up, where a required visit is not completed, or where continuing would be inconsistent with applicable law or professional standards.

Where treatment is discontinued, the Medical Group will make reasonable efforts to notify you and to advise you on obtaining continuing care.

15. WITHDRAWING YOUR CONSENT

You may withdraw this Consent at any time, without prejudice to future care and without loss of any benefit to which you are otherwise entitled.

Withdrawal takes effect when written notice is received by the Medical Group at hq@nexlife.com / care@nexlife.com or by mail at the address in Section 19.

Because Providers who furnish services through the Service do not offer in-person care, withdrawing consent to telehealth means you will need to obtain care elsewhere. Do not stop a prescribed medication without first consulting a licensed healthcare professional.

Withdrawal does not affect any action taken by Nexlife, the Medical Group, or a Provider in reliance on this Consent before the notice was received. Withdrawal does not affect the remaining provisions of this Consent, the Terms & Conditions, or the Privacy Policy.

16. CHANGES TO THIS CONSENT

This Consent may be amended. Material changes will be communicated to you through the Service or by email, and continued use of the Service after the effective date of a material change constitutes acceptance. The current version and its effective date appear at the top of this document. Prior versions are available on request.

17. STATE-SPECIFIC PROVISIONS

Certain states impose additional or different requirements on telehealth informed consent, including mandatory disclosure language, requirements that consent be obtained verbally as well as in writing, requirements that the patient be informed of the Provider's identity, credentials, and physical location, restrictions on asynchronous prescribing, and specific complaint-procedure disclosures.

Where the law of your state requires terms different from or additional to those in this Consent, the requirements of your state govern. State-specific provisions are set out in Schedule A.

Notice to California residents

Physicians are licensed and regulated by the Medical Board of California. To confirm a license or file a complaint, visit www.mbc.ca.gov or call (800) 633-2322.

18. YOUR ACKNOWLEDGMENTS

By accepting this Consent, you acknowledge and agree that:

  1. You are at least 18 years of age.
  2. You have read this Consent, have had the opportunity to ask questions, and understand it.
  3. Clinical services are provided by Nexlife Medical Group P.C., not by Nexlife Inc., and Nexlife Inc. has a financial relationship with the Medical Group (Section 2.3).
  4. Your Provider may be a physician assistant or nurse practitioner rather than a physician.
  5. Your care may be delivered asynchronously, and you may receive a diagnosis, treatment plan, and prescription without a live conversation with your Provider (Section 3.1).
  6. No diagnosis, treatment, outcome, or benefit is guaranteed. Your condition may not improve and may worsen.
  7. Telehealth has the risks and limitations described in Section 5, including that a physical examination cannot be performed and that conditions may go undetected.
  8. It is your responsibility to provide truthful, accurate, and complete health information, and that failing to do so may result in serious harm, including death (Section 6).
  9. Your Provider may prescribe a compounded medication that is not FDA-approved and has not been evaluated for safety, effectiveness, or quality, and that FDA-approved alternatives exist (Section 8).
  10. You have been directed to the Important Safety Information, including the boxed warning, and have had the opportunity to read it (Section 8.5).
  11. You understand the multi-dose vial dosing instructions, including that doses are measured in milligrams or milliliters, not insulin units (Section 8.4).
  12. Telehealth is not appropriate for emergencies, and you will call 911 or 988 as described in Section 7.
  13. Completing an assessment or making a payment does not entitle you to a prescription (Sections 2.6 and 10.1).
  14. You may have your prescription filled at any pharmacy of your choosing (Section 10.3).
  15. Laboratory tests may produce inaccurate results (Section 11).
  16. You are responsible for the full cost of services and medications and will not submit any claim to insurance or any federal healthcare program (Section 12).
  17. In-person care is an alternative, you are free to seek care from any provider not affiliated with Nexlife or the Medical Group, and you have been informed of treatment alternatives (Sections 3.3 and 13).
  18. Telehealth is an evolving field, and your care may involve technology not specifically described in this Consent.
  19. You may withdraw this Consent at any time as described in Section 15.

19. CONTACT AND COMPLAINTS

Nexlife Inc.  300 Delaware Ave, Wilmington, DE 19801 hq@nexlife.com | (949) 818-8000

Nexlife Medical Group P.C.  300 Delaware Ave, Wilmington, DE 19801

Clinical questions should be directed to your Provider through the Service. Adverse reactions should be reported to your Provider, to the dispensing pharmacy, and to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.